Development and Validation of a NIRS-based Sinusitis Screening
The research at UCI Beckman laser institute and Praxis Biosciences LLC, develope near-infrared (NIR) trans-illumination methods. The optical imaging tool that can determine acute sinusitis and the response to treatment therapy.
|Study Design:||Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Screening
|Official Title:||Development and Validation of a NIRS-based Sinusitis Screening|
- Optical imaging NIR tool to assess of sinusitis [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]Assessment of sinusitis and the response to the treatment.
|Study Start Date:||September 2011|
|Estimated Study Completion Date:||July 2016|
|Estimated Primary Completion Date:||July 2016 (Final data collection date for primary outcome measure)|
No Intervention: Sinusitis Screening
Device: Sinusitis Screening
In the United States, approximately one in seven people develop sinusitis each year, and 20 million cases of acute bacterial sinusitis become chronic to require medical treatment. The NIR light from the illumination wand travelled through the pallet into the sinuses and exited the face. The NIR device can determine air-filled and fluid/tissue-filled spaces in the sinus cavity during clinical exam.
|United States, California|
|UCI Beckman Laser Medical Clinic|
|Irvine, California, United States, 92612|
|Principal Investigator:||Albert Cerussi, PhD||UCI Beckman Laser Institute|